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A B S T R A C T
Lonicera japonica Thunb. has been widely used as food ingredients and healthy drinks in the Asian countries,
which was reported to possess some good activities. However, it remains unknown in the immunomodulation of
Lonicera japonica polysaccharides (LJP) on allergic rhinitis (AR). This study aimed to investigate the impact of
LJP on ovalbumin-induced AR in BALB/c mice model. LJP significantly inhibited AR symptoms and eosinophil
number in nasal mucosa. Besides, the increased serum levels of IgE, TNF-α, IL-1β and IL-17 were markedly
decreased when AR mice were treated with LJP. The mRNA expression levels of IL-4, IL-5, IL-6, IL-17, IL-23,
ROR-γt and STAT3 in OVA group were increased, and SOCS3 was reduced, while LJP inhibited the changes. The
present study indicated that LJP suppressed the inflammatory response in AR sensitized by ovalbumin, showing
that LJP has the potential to treat AR through the regulation of Th17 cells.
1. Introduction
Allergic rhinitis (AR) is a common allergic disease which is suffered
by many people around the world (Suzuki, Yokota, Nakamura, Ozaki, &
Murakami, 2017). It is one of the risk factors for asthma development in
adults and children (Guerra, Sherrill, Martinez, & Barbee, 2002). The
prevalence of this kind of allergic airway inflammation ranges from 8.7
to 24.1% and has been increased in China (Zhang & Zhang, 2014;
Zhang et al., 2009). According to a study, one in three AR patients may
contribute to the development of asthma within 10 years (Li et al.,
2016). Poor asthma control and outcome may happen due to the
asthma management complicated by AR (Lohia, Schlosser, & Soler,
2013).
Allergic rhinitis is a typical allergic disease involving elevation of
immunoglobulin E (IgE) production and influx of inflammatory cells,
such as mast cells and eosinophils, into nasal mucosa (Oboki, Ohno,
Saito, & Nakae, 2008; Tran, Vickery, & Blaiss, 2011). It is characterized
by inflammation of the nasal mucosa with hypersensitivity, which is
resulted from perennial or seasonal responses to specific environmental
allergens. Besides, AR is also characterized by symptoms such as
rhinorrhea, lacrimation, nasal rubbing, sneezing, nasal congestion and
obstruction, and less frequently cough (Jung, Jung, Cho, Kang, & Park,
2012). Some studies of Allergic rhinitis have suggested that an im-
balance of Th1/Th2 is an important factor (Wang et al., 2018; Yu et al.,
2017). Additionally, an increase in Th2 in this imbalance is considered
as the main cause of AR, and thus it is more important to evaluate Th2
than Th1 (Saeki et al., 2019). Furthermore, Th17 cells promote eosi-
nophilia airway inflammation that is mediated by Th2 cells (Wakashin
et al., 2008). Therefore, a lot of researchers are interested to find out a
therapeutic strategy in order to shift the immune response towards
Th17 in recent years (Liu et al., 2018).
Lonicera japonica Thunb, also known as Jin Yin Hua in China, is
planted widely in Fengqiu county of Henan province, and it is widely
used as food, food ingredients, healthy drinks and traditional medicine
in the Asian countries (Shang, Pan, Li, Miao, & Ding, 2011). The flowers
of Lonicera japonica Thunb. have been used as the traditional medicine
for treatment of wind-heat type of common cold, sore throat, epidemic
febrile diseases and so on for thousands of years. Due to the pharma-
cological effects mentioned above, Lonicera japonica Thunb. is both
listed as “Top Grade” in “Shen Nong Ben Cao Jin” and “Ben Cao Gang
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Mu” (Shang et al., 2011), Lonicera japonica Thunb. is listed in the
Pharmacopoeia of the People’s Republic of China used to treat various
diseases. In numbers of the modern pharmacological studies, Lonicera
japonica Thunb. has been well characterized to possess a wide spectrum
of biological and pharmacological effects including antiviral, anti-in-
flammatory, antibacterial and other effects (Shang et al., 2011). Owing
to its extensive pharmacological effects, lots of the chemical compounds
in Lonicera japonica Thunb. have been identified extensively. Poly-
saccharide, chlorogenic acid and essential oils as the main components
have been purified and studied. Among of them, polysaccharide has
been acknowledged with some good pharmacological effects. Tian et al.
reported a polysaccharide (LJP-1), purified from the flower of Lonicera
japonica Thunb., could prevent the development of picryl chloride-in-
duced allergic contact dermatitis (Tian, Che, Ha, Wei, & Zheng, 2012).
Different extracts of Lonicera japonica can suppress inflammatory
factors and inhibit inflammatory reactions. In A549 cells, aqueous ex-
tracts from flower of this plant could inhibit expression of IL-1β induced
COX-2 protein and mRNA, as well as COX-1 and COX-2 activity (Xu,
Oliverson, & Simmons, 2007). In addition, Lonicera japonica inhibited
TNF-α secretion at a dose-dependent manner after stimulation of
trypsin in the examination of the effect of water fraction of this plant on
trypsin-induced mast cell activation (Kang et al., 2004). Previous stu-
dies showed that Lonicera japonica is safe to be used in treatment of
inflammatory disorders (Shang et al., 2011). In the present study, Lo-
nicera japonica Thunb. was used to as a therapeutic agent to treat AR.
However, the effect of LJP in the management of AR is not yet certain.
The objective of this study was to evaluate the immunomodulatory
effects of LJP on the OVA-induced AR in mice model.
2. Materials and methods
2.1. Materials
The flowers of Lonicera japonica Thunb. were purchased from
Fengqiu county local Market (Henan, China), which were identified by
one of the authors (T. Z.). Various dextrans (2000 kDa, 800 kDa,
100 kDa, 50 kDa, 10 kDa), as well as monosaccharides mannose (Man),
rhamnose (Rha), glucuronic acid (GlcA), galacturonic acid (GalA),
glucose (Glc), galactose (Gal), xylose (Xyl), arabinose (Ara) and fucose
(Fuc) were all purchased from Sigma. Sepharose CL-6B was purchased
from GE Healthcare.
2.2. Animals
Forty healthy eight-week-old female BALB/c mice, weighing
20 ± 2 g, were purchased from the Experimental Animal Centre of
Third Military Medical University (Army Medical University),
(Chongqing, China). The mice were maintained under specific-pa-
thogen-free conditions in an animal room at a temperature of
22 ± 3 °C and a relative humidity of 40% - 70% with a 12/12-h light/
dark cycle and free access to food and water. They were maintained on
an ovalbumin (OVA)-free diet. The experimental procedures were ap-
proved by the ethical committee of Zunyi Medical University.
2.3. Preparation of Lonicera japonica Thunb. Polysaccharide
Preparation of Lonicera japonica Thunb. polysaccharide according to
our previously published method (Zhang, Xiang, Zheng, Yan, & Min,
2018). The flowers of Lonicera japonica Thunb. were first extracted with
95% ethanol under reflux for four hours (three times) to remove hy-
drophobic compounds and then the residue (500 g) was extracted with
hot distilled water (10 L, 100 °C) two times (four hours for each). The
extractions were filtered, combined and concentrated to 700 mL and
treated with 15% trichloroacetic acid at 4 °C for four hours for protein
removal. After neutralization, anhydrous ethanol was added up to 75%
to precipitate the polysaccharide which was collected and dried in
vacuum to obtain Lonicera japonica polysaccharide (LJP, yield 5.1%, w/
w).
2.4. LJP monosaccharide composition analysis
LJP monosaccharide composition analysis using our previously
published method. LJP (2 mg) was hydrolyzed with 2 M TFA at 110 °C
for five hours and the released monosaccharides were derivatized by 1-
phenyl-3-methyl-5-pyrazolone (PMP). The derivatives were analyzed
by high performance liquid chromatography (e2695, Waters) with a
DiKMA Platisil ODS column (4.6 × 250 mm) and a 2489 UV/Vis de-
tector (Waters). The column was eluted with 82.0% PBS (0.1 M, pH 7.0)
and 18.0% acetonitrile (v/v) at a flow rate of 1.0 mL/min and mon-
itored by UV absorbance at 245 nm (Zhang et al., 2018).
2.5. Molecular weight detection
Molecular weights were determined by gel-permeation chromato-
graphy on a Sepharose CL-6B column (1.0 × 90 mm) and eluted with
0.15 M NaCl at a flow rate of 0.15 mL/min. The eluates (1.8 mL per
tube) were collected and assayed for total sugar content using the
phenol–sulfuric acid method (Zhang et al., 2018). The columns were
calibrated by various dextrans (2000 kDa, 800 kDa, 100 kDa, 50 kDa,
10 kDa). The molecular weight of the LJP was calculated using linear
regression analysis.
2.6. Fourier-transform infrared analysis
Fourier-transform infrared spectroscopy of LJP was detected using
potassium bromide (KBr) pellet assay (LJP was ground with KBr and
pressed to be a polymer film) on a Varian-1000 spectrophotometer in
the range of 500–4000 cm−1.
2.7. Establishment of the murine model of AR and treatment
Allergen sensitization, challenge for development of AR murine
model and treatment were summarized as shown in Fig. 1A. Mice were
divided into five groups, with eight mice in each group (Control group:
negative control group, OVA group: positive control group, Loratadine
group: 10 mg/kg loratadine treatment group, LJP-L group: 30 mg/kg
LJP treatment group and LJP-H group: 100 mg/kg LJP treatment
group). The mice from OVA group, Loratadine group, LJP-L group and
LJP-H group were sensitized on days 0, 2, 4, 6, 8, 10, 12 and 14 by
intraperitoneal (i.p.) injection with 100 μg OVA (Sigma-Aldrich, St.
Louis, MO, USA) mixed with 2 mg aluminum hydroxide in 200 μL/
mouse saline. The mice were then challenged by intranasal treatment of
200 μg OVA in 20 μL saline per mouse for 10 consecutive days, from
days 20 to 29 (Gu, Wang, & Cao, 2017). The Loratadine group, LJP-L
group and LJP-H group were intraperitoneally injected with the ther-
apeutic drugs, whereas the OVA group was injected with saline at
30 min before the challenge. The mice from Control group were sen-
sitized and challenged with saline instead of OVA at all stages.
2.8. Evaluation of nasal symptoms
The mice were immediately placed in observation cages (one
mouse/cage) and the numbers of sneezing and rubbing were counted
for 15 min by a blinded observer to evaluate early allergic responses
after the last nasal challenge on day 29 (Zhang, Han, Kim, Lee, & Rhee,
2017). The observation of sneezing in mice was self-optimized: Re-
cognition of sneezing mice requires a quiet environment where ob-
servers can watch carefully. Sneezing could be recognized by sound and
neck movement. The sound is very slight, and the mouse's head slightly
and rapidly shakes.
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2.9. Histopathological evaluation of nasal cavity
Nasal tissues were separated using previously published methods
with a slight modification (Miyata et al., 2008; Suzuki, Matsumoto,
Ohta, Min, & Murakami, 2007). When mice were painlessly sacrificed
by cervical dislocation, nasal septum mucosal tissues from four mice in
each group were fixed with paraformaldehyde, embedded in paraffin,
sectioned coronally into 4-μm slices and stained with hematoxylin and
eosin (H&E) or Sirius red to count eosinophil. Sections were im-
munostained with the TNF-α (Proteintech, Wuhan, China) antibody and
subsequently with IgG (Boster, Wuhan, China). Bound antibodies were
visualized by 3,3′-diaminobenzidine (DAB) kit (Boster, Wuhan, China).
The pathomorphology of the mouse nasal mucosa was observed under
an optical microscope. The number of eosinophils in submucosal region
of the nasal septum was quantified under a microscope in four fields at
×200 magnification in a blinded manner.
2.10. Enzyme-linked immunosorbent assay (ELISA) for cytokines
The concentrations of IgE, IL-1β, TNF-α and IL-17 in the serum were
determined using ELISA kits (IL-17: Abcam, Cambridge, UK; IgE, TNF-
α: Invitrogen, Vienna, Austria; IL-1β: Invitrogen, San Diego, CA, USA)
according to the manufacturers’ instructions.
2.11. RNA extraction and real-time quantitative PCR analysis
Total RNA in the nasal mucosa samples was isolated with RNAiso
Plus (TaKaRa, Kusatsu, Shiga, Japan). The RNA was quantified by
measuring the absorbance at 260 nm and the purity of RNA was assayed
by the ratio of absorbance at 260 nm and 280 nm. By following the
instructions of the PrimeScript™ RT reagent kit (TaKaRa, Kusatsu,
Shiga, Japan), 1 μg of total RNA was reverse transcribed to cDNA.
Quantitative PCR amplification was performed with a 15 µL-final re-
action mixture, consisting of 0.1 µM of both the sense and antisense
primers (Table 1), iQTM SYBR® Green Supermix (Bio-Rad, USA) and
cDNA. Gene expression was normalized to the corresponding β-actin (as
a housekeeping gene) level and presented as the fold difference relative
to β-actin. The mRNA was analyzed using CFX Connect Real-Time
System (Bio-Rad, USA) with the following conditions: 3 min at 95 °C,
followed by 40 cycles for 10 s at 95 °C, 45 s at 60 °C.
2.12. Western blot analysis
Protein was obtained from the nasal mucosa of three mice in each
Fig. 1. Experimental protocol and nasal symptoms. (A) Schematic diagram of the experimental protocol in mice (n = 8 per group). The numbers of (B) sneezing and
(C) rubbing counted over a 15-min period after the last nasal challenge on day 29. Data are presented as mean ± standard deviation (SD). ***P < 0.001 vs. Control
group; ##P < 0.01, ###P < 0.001 vs. OVA group.
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group at 24 h after the final nasal challenge. The nasal mucosa was
washed twice with PBS (Solarbio, Beijing, China) and 100 µL of RIPA
Lysis Buffer (Beyotime Biotechnology, Haimen, Jiangsu, China) then
added to each well to lyse nasal mucosa on ice for about 30 min. Next,
the mixture was centrifuged at 12,000 rpm and 4 °C for 10 min and the
supernatant was collected. Protein concentrations were determined
using BCA protein assay reagent (Beyotime Biotechnology, Haimen,
Jiangsu, China). Total protein (30 μg) were loaded on 12% SDS poly-
acrylamide gels, separated electrophoretically transferred onto
Nitrocellulose Blotting Membrane (NC) membranes (GE Healthcare Life
science, Dassel, Germany). The membranes were stained with 0.2%
Ponceau S red to assure equal protein loading and transferring. The
membranes were blocked with 5% no-fat milk (dissolved in TBST),
followed by incubation with the appropriate primary antibodies: rabbit
anti-ROR-γt (1:1000, Abcam, Cambridge, UK), rabbit anti-STAT3
(1:1000, Cell Signaling Technology, Boston, USA), rabbit anti-p-STAT3
(1:1000, Cell Signaling Technology, Boston, USA), rabbit anti-SOCS3
(1:1000, Abcam, Cambridge, UK), rabbit anti-β-actin (1:1000,
Proteintech, Rosemont, IL, USA at 4 °C for overnight. They were then
washed thrice with TBST before the membranes were reacted with
horseradish peroxidase-conjugated secondary antibody (1:5000) for
one hour at room temperature. The membranes were visualized by
chemiluminescence using ECL detection reagents (Millipore
Corporation, Billerica MA, USA) and exposed to X-ray films. Results
were normalized to the internal control β-actin and the optical density
was quantified by Image J 1.8.0 software.
2.13. Statistical analysis
Experimental values were expressed as means ± standard devia-
tion of at least three experiments in triplicate. One-way ANOVA was
used to evaluate the data statistic differences using Tukey's HSD test
(SPSS 22.0 software, SPSS, Chicago, IL, USA). The level of P-value less
than 0.05 was expected to denote statistical significance.
3. Results
3.1. Characterization of LJP
The total carbohydrate, uronic acid and protein content of LJP are
83.1%, 19.3% and 0.5% respectively. The monosaccharide composition
of LJP is shown in Fig. 2A. The results showed that LJP was mainly
composed of GalA (8.7%), Rha (8.2%), Gal (16.2%), Ara (19.5%), Glc
(26.9%) and Man (20.5%). The ratio of Rha/GalA is 0.94, falling in RG-I
type range from 0.05 to 1.0 as defined by Schols and Voragen (1996),
which suggested that LJP may contain some RG-I pectin domain. The
content of Gal and Ara is 35.7%, showing that LJP may contain
galactan, arabinan, and/or arabinogalactan. Furthermore, LJP contains
a certain amount of Glc and Man, suggesting that the existence of some
mannan and glucan. The molecular weight distribution of LJP is shown
in Fig. 2B, which showed that LJP is heterogeneous ranging from
10 kDa to 1000 kDa approximately.
The basal structural characteristics of LJP was determined by
Fourier-transform infrared spectroscopy (Fig. 2C). The characteristic
absorbance of LJP at around 3420 cm−1 and 1624 cm−1 are assigned to
the hydroxyl stretching vibration and hydroxyl bending vibration re-
spectively (Cui et al., 2008). 2919 cm−1 and 1418 cm−1 are assigned to
CeH stretching vibration and CeH bending vibration respectively.
1099 cm−1 is assigned to CeOeH while 775 cm−1 is assigned to pyr-
anose vibrates symmetrically. All these characteristic peaks mentioned
above were distinctive absorptions of polysaccharide.
3.2. Effects of LJP on nasal symptoms in AR mice model
The effects of LJP on nasal symptoms are shown in Fig. 1B and C.
The frequencies of rubbing and sneezing in the OVA group were dra-
matically higher than that in the Control group (***P < 0.001 vs.
Control group). Treatment of allergic rhinitis with either 30 or 100 mg/
kg LJP and 10 mg/kg loratadine significantly decreased the number of
nasal rubbing movements as compared to the OVA group (Fig. 1B,
###P < 0.001 vs. OVA group). Moreover, as compared to the OVA
group, the number of nasal sneezing movements in the Loratadine
group (##P < 0.01 vs. OVA group), LJP-L group (##P < 0.01 vs. OVA
group) and LJP-H group (###P < 0.001 vs. OVA group) were reduced
significantly (Fig. 1C). High-dose LJP was more effective than lor-
atadine, followed by low-dose LJP in attenuating the sneezing move-
ments of mice.
3.3. Effects of LJP on histopathological changes in AR and expression of
TNF-α in nasal mucosal tissues of mice
Histological analysis revealed evident infiltration of inflammatory
cells, such as eosinophils and notable epithelial proliferation in the
OVA-challenged mice (Fig. 3). The number of eosinophils was increased
significantly in the OVA group as compared to the Control group
(Fig. 3B and D, ***P < 0.001 vs. Control group). Drug treatment of
loratadine and LJP dramatically reduced the increased number of eo-
sinophils in AR mice (###P < 0.001 vs. OVA group). In addition, the
results show that a higher dose of LJP was more effective in decreasing
the eosinophil number than a lower dose of LJP, as well as loratadine.
The immunohistochemical staining of TNF-α expression in nasal
mucosal tissue was more intense in the OVA group than in the Control
group (Fig. 3F, ***P < 0.001 vs. Control group). Both loratadine and
LJP significantly reduced the expression of TNF-α induced by admin-
istration of OVA (Loratadine group and LJP-L group: #P < 0.05 vs.
OVA group; LJP-H group: ##P < 0.01 vs. OVA group). Besides, TNF-α
expression in the LJP-H group was lower than that in the LJP-L group,
indicating that a higher dose of LJP had a better therapeutic effect than
a lower dose of LJP on the treatment of allergic rhinitis in mice model.
3.4. Effects of LJP on the release of IgE and inflammatory cytokines in
serum
The serum levels of IgE, TNF-α, IL-1β and IL-17 in the OVA group
were increased significantly compared with those in the Control group
(Fig. 4, ***P < 0.001 vs. Control group). Drug treatment of loratadine
dramatically decreased the concentrations of IgE (###P < 0.001 vs.
OVA group) and inflammatory cytokines (IL-1β, ##P < 0.01 vs. OVA
group; TNF-α, IL-17, ###P < 0.001 vs. OVA group) in the serum of AR
mice. Besides, the concentrations of IgE and inflammatory cytokines
examined in the LJP-L and LJP-H groups were also reduced dramati-
cally compared with those in the OVA group (###P < 0.001 vs. OVA
group). Hence, our results show that high-dose LJP could effectively
Table 1
Real-time PCR primer sequences.
Target gene Direction Sequence
IL-17 Forward primer 5′-TCACTCCTGCTGATTCGGGT-3′
Reverse primer 5′-CTCAGTGCCACCTCCAGACT-3′
IL-23 Forward primer 5′-ACCTGTAGTGGTGGTGGTGGAG-3′
Reverse primer 5′-GGACCAGATAACTGTTGGCAGAGC-3′
IL-5 Forward primer 5′-CCTCATCCTCTTCGTTGCATCAGG-3′
Reverse primer 5′-TGATCCTCCTGCGTCCATCTGG-3′
IL-4 Forward primer 5′-TACCAGGAGCCATATCCACGGATG-3′
Reverse primer 5′-TGTGGTGTTCTTCGTTGCTGTGAG-3′
IL-6 Forward primer 5′-ACTTCCATCCAGTTGCCTTCTTGG-3′
Reverse primer 5′-TTAAGCCTCCGACTTGTGAAGTGG-3′
SOCS3 Forward primer 5′-CTGCTCTTACGACCGCTGTCTCG3′
Reverse primer 5′-ATGTTGGCAGCCGTGAAGTCTAC-3′
STAT3 Forward primer 5′-GCATGGAGGCGTGTCTTGGC-3′
Reverse primer 5′-TGTACCTCAGCGATCCGGTTAGG-3′
ROR-γt Forward primer 5′-TCACTCCTGCTGATTCGGGT-3′
Reverse primer 5′-CTCAGTGCCACCTCCAGACT-3′
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suppress the concentrations of inflammatory cytokines (i.e. TNF-α and
IL-1β) and IgE in serum, followed by low-dose LJP and loratadine.
However, loratadine decreased IL-17 level more effective than lower
dose of LJP.
3.5. Effects of LJP on T cells related-cytokine mRNA expression levels in
mouse nasal mucosa
Determination of T cells related-cytokine mRNA expression levels in
nasal mucosa of AR mice was performed by RT-PCR analysis. Repeated
application of OVA dramatically increased mRNA relative expression
levels of IL-4 (**P < 0.01 vs. Control group), IL-5 (***P < 0.001 vs.
Control group), IL-6 (***P < 0.001 vs. Control group), IL-17
(***P < 0.001 vs. Control group) and IL-23 (***P < 0.001 vs. Control
group) (Fig. 5A–E).
Based on the results, loratadine and LJP could inhibited the
changes. Loratadine significantly reduced the concentrations of IL-5
(#P < 0.05 vs. OVA group), IL-6 (##P < 0.01 vs. OVA group), IL-17
(#P < 0.05 vs. OVA group). Although loratadine could lower the
concentrations of IL-4 and IL-23 in AR mice, however, there were no
significant differences for these two cytokines between the OVA group
and the Loratadine group. The mRNA expression levels of IL-4
(#P < 0.05 vs. OVA group), IL-6 (##P < 0.01 vs. OVA group), IL-17
(##P < 0.01 vs. OVA group), IL-23 (#P < 0.05 vs. OVA group).
However, the mRNA expression levels of IL-5 in the LJP-L group did not
show significant difference as compared to the OVA group, although
our results indicate that the lower dose of LJP could lower such con-
centrations. In the comparison between the LJP-H group and the OVA
group, our results demonstrate that the LJP-H group could dramatically
decreased the mRNA expression levels of IL-4 (##P < 0.01 vs. OVA
group), IL-5 (##P < 0.01 vs. OVA group), IL-6 (###P < 0.001 vs. OVA
group), IL-17 (###P < 0.001 vs. OVA group), IL-23 (##P < 0.01 vs.
OVA group). According to our experimental results, the concentrations
of cytokines in the LJP-H group were the lowest among the drug
treatment groups, indicating that the higher dose of LJP has better
therapeutic effects in order to treat AR mice.
3.6. Effects of LJP on STAT3, ROR-γt and SOCS3 expressions in AR mice
Two methods were used to detect the STAT3, ROR-γt and SOCS3
expression levels in nasal mucosa of AR mice. Expression levels of
mRNA were performed by RT-PCR analysis. Repeated application of
OVA dramatically increased mRNA relative expression levels of STAT3
(***P < 0.001 vs. Control group) and ROR-γt (***P < 0.001 vs. Control
group), but significantly decreased the mRNA relative expression level
of SOCS3 (*P < 0.05 vs. Control group). Similarly, loratadine and LJP
can alleviate these changes. Loratadine significantly reduced the con-
centrations STAT3 (#P < 0.05 vs. OVA group) and ROR-γt (#P < 0.05
vs. OVA group). In contrast, SOCS3 mRNA expression level in the
Loratadine group was increased compared with the OVA group, but the
difference was not statistically significant. ROR-γt (###P < 0.001 vs.
OVA group) in the LJP-L group were significantly reduced as compared
to the OVA group. However, the change of STAT3 was not observed.
The concentration of SOCS3 in the LJP-L group was increased without
any significant difference compared with those in the OVA group. In the
comparison between the LJP-H group and the OVA group, our results
demonstrate that the LJP-H group could dramatically decreased the
mRNA expression levels ROR-γt (###P < 0.001 vs. OVA group) and
STAT3 (##P < 0.01 vs. OVA group), but significantly increased the
mRNA expression level of SOCS3 (#P < 0.05 vs. OVA group)
(Fig. 6G–I).
Western blotting was carried out to determine the protein expres-
sion of STAT3, SOCS3 and ROR-γt, which were the regulatory proteins
of Th17 differentiation. OVA treatment significantly increased the
phosphorylation of STAT3 (Fig. 6A) and the expression of ROR-γt
(Fig. 6B), whereas significantly decreased the SOCS3 expression
Fig.2. Characterization of LJP. (A) Monosaccharide composition of LJP. (B) Chromatography of LJP at absorbance wavelength of 490 nm. (C) Infrared spectrum of
LJP.
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(Fig. 6C) (*P < 0.05 vs. Control group). The phosphorylation of STAT3
in Loratadine and LJP-L groups were lowered compared with OVA
group, but these two drug treatment groups and OVA model group did
not show any significant difference. STAT3 expression in LJP-H group
was markedly suppressed as compared to that in OVA group
(##P < 0.01 vs. OVA group). Hence, the results proved that higher
dose of LJP had better therapeutic effect than lower dose of LJP and
loratadine in treating allergic rhinitis induced by OVA.
Our experiment showed that loratadine (#P < 0.05 vs. OVA group)
and high-dose LJP (##P < 0.01 vs. OVA group) could significantly
lower the expression of ROR-γt in OVA-induced mice. Low-dose LJP
could also reduce ROR-γt expression when compared with OVA group,
however, there is no significant difference between these two groups.
Based on the results obtained, ROR-γt expression could be effectively
suppressed by high-dose LJP, followed by loratadine and low-dose LJP.
Alternative results were obtained in the case of SOCS3, at which
SOCS3 expression was increased by loratadine, followed by lower and
higher dose of LJP. Results showed that high-dose of LJP significantly
increased the expression of SOCS3 as compared with OVA group
(#P < 0.05 vs. OVA group), while there were no significant differences
between Loratadine, LJP-L and OVA groups.
4. Discussion
The present study is the first research which demonstrates the ef-
fects of LJP on OVA-induced allergic rhinitis. The results obtained in
this report suggest that LJP has therapeutic effects on AR via Th17 cell
regulation.
Allergic rhinitis is just an allergic inflammatory disease with nasal
symptoms, such as nasal blockage, rhinorrhea, sneezing and scratching
of nose (Skoner, 2001). Medicinal herbs, the traditional medicines, are
commonly used in Asian countries such as China and Korea (Marini-
Bettolo, 1980). As most herbs are highly available, low-cost and have
no toxicity, researchers are interested in the use of herbs and their
bioactive compounds (Song et al., 2016). Plant polysaccharides can
improve immune function of a body, activate immune cells and inhibit
tumor growth (Bao, Qian, Gong, & Shen, 2017). In the present study,
polysaccharides were isolated from Lonicera Japonica flowers to treat
AR disease. First, the LJP was isolated, and the monosaccharide com-
position was analyzed. However, these monosaccharide components
are not sufficient to explain their effects. Additional studies are needed
to separate and purify LJP to obtain different types of polysaccharide
domains or structural units to further study the activity and fine
structure of different domains or structural units and clarify the main
active ingredients and their structure-activity relationships in LJP.
Clinical symptoms such as itching, sneezing, eosinophil recruitment,
Fig. 3. Histopathological analysis and immunohistochemistry of mouse nasal mucosal tissues respectively (n = 4 per group). (A, B and C, D) H&E staining and Sirius
red staining respectively. (E and F) Immunohistochemical staining. Data are presented as mean ± standard deviation (SD). ***P < 0.001 vs. Control group;
#P < 0.05, ##P < 0.01, ###P < 0.001 vs. OVA group.
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IgE production and cytokine expression are generated due to AR in-
duced by OVA administration (Jeong, Oh, Lee, & Kim, 2014; Zhou,
Chen, Zhang, Zhu, & Cheng, 2012). In this research, allergic in-
flammation in the OVA group was characterized by airway eosinophilic
infiltration, along with increased cytokines of Th1, Th2 and Th17. The
number of nasal sneezing and rubbings was elevated in AR mice sen-
sitized by OVA. Serum level of IgE in mice was also significantly raised
in the OVA group.
IL-17 is a cytokine produced by Th17 cells. Its expression in nasal
mucosa was associated with clinical severity of AR and nasal eosino-
philia (Makihara et al., 2014). The function of IL-17 is to trigger the
inflammation of tissue through production of chemokines and pro-in-
flammatory cytokines. It also induces cell activation of allergen-specific
Th2, accumulation of eosinophil and production serum IgE in asthma
(Quan, Zhang, Han, Iwakura, & Rhee, 2012; Wang & Liu, 2008). Ac-
cording to a previous study, blocked IL-17 did not reduce the number of
sneezing and rubbings of AR mice (Lohia et al., 2013). However, an-
other study found that increased sneezing and rubbing motions could
Fig. 4. Concentrations of IgE, TNF-α, IL-1β and IL-17 in mice serum which were quantified by enzyme-linked immunosorbent assay (ELISA) (n = 8 per group). Data
are presented as mean ± standard deviation (SD). ***P < 0.001 vs. Control group; ##P < 0.01, ###P < 0.001 vs. OVA group.
Fig. 5. mRNA expression levels of IL-4, IL-5, IL-6, IL-17 and IL-23 in nasal mucosa of mice which were examined by RT-PCR analysis (n = 4 per group). Data are
presented as mean ± standard deviation (SD). **P < 0.01, ***P < 0.001 vs. Control group; #P < 0.05, ##P < 0.01, ###P < 0.001 vs. OVA group.
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be reduced by lowering IL-17 level (Gu, Wang, & Cao, 2017). The
second report is consistent with our result at which loratadine and LJP
significantly decreased IL-17 concentration, thus diminishing the
sneezing and rubbing number in OVA-induced mice.
Infiltration of eosinophils is one of the characteristics of AR (Broide,
2010; Trivedi & Lloyd, 2007). Chemoattractant produced by T cells,
epithelium and mast cells recruits eosinophil to nasal mucosa (Lotfi
et al., 2009; Trivedi & Lloyd, 2007). Immunohistochemistry of nasal
mucosa demonstrates that eosinophils within the epithelium and sub-
mucosa in those with symptomatic rhinitis (Bentley et al., 1992;
Bradding et al., 1993). After eosinophilic infiltration from the blood
into tissue, eosinophils are involved in the late-phase reaction. Th2 cells
secrete cytokines that recruit and activate eosinophils in the nose.
Furthermore, human eosinophils synthesize and express several cyto-
kines including TNF-α. Hence, eosinophils play an important role in
allergic inflammation because they are recruited to allergic sites where
their cationic proteins, lipid mediators and cytokines contribute to
dysfunction and damage of other cell types (Al Suleimani & Walker,
2007). Based on the present data, increased eosinophils in the OVA
group triggered the synthesis of cytokines, leading to AR disease. On the
other hand, AR could be attenuated after the application of loratadine
and LJP by decreasing eosinophil number.
The inflammatory response in allergic diseases such as AR, food
allergies and asthma is mediated by IgE (Gould & Sutton, 2008). In-
flammatory mediators and Th2 cytokines, such as IL-5 are generated
due to mast cell activation. An important cytokine for Th2 phenotype,
that is IL-4, triggers IgE production (Ueda, Chandswang, & Ovary,
1990). Our experiment showed that the increased level of IL-4 led to a
significant increase in the serum level of IgE in the OVA group. In
contrast, both concentrations were lowered after treatment with lor-
atadine and LJP.
The regulation of helper immune function by lineages of Th1 and
Th2 cells contributes to the immunologic imbalance characteristic of
the allergic state. Th1 lineage is normally driven by IL-2 and TNF-α
(Deo, Mistry, Kakade, & Niphadkar, 2010). TNF-α plays a major role in
acute and chronic inflammation (Holtmann, Schuchmann, Zeller, Galle,
& Neurath, 2002). It stimulates the expression of a series of immune
mediators and inflammatory mediators (Ozbey, Gorczynski, & Erin,
2014). TNF-α released from mast cells and platelets resulted in in-
creased vascular permeability and tissue swelling. Inflammation is at-
tenuated when TNF-α is reduced (Tian et al., 2012). Based on the data
in present study, LJP administration significantly decreased TNF-α level
in serum and nasal mucosal tissue. Results obtained indicate that the
anti-allergic effect of LJP resulted from its reduction of TNF-α, de-
creasing the permeability of endothelial cell monolayers to macro-
molecules and lower molecular weight (Tian et al., 2012). LJP had a
good regulatory effect on OVA-induced AR in mice as shown in our
analyses.
As part of the nasal mucosal barrier, epithelial cells produce pro-
inflammatory cytokines and chemokines that cause AR (Calderón,
Devalia, Prior, Sapsford, & Davies, 1997). In-vitro nasal epithelial cells
from non-atopic individuals generate lower concentration of IL-1β as
compared to those from atopic individuals (Nonaka, Nonaka, Jordana,
& Dolovich, 1996). Nasal epithelial cells from human with a genetic
predisposition to upper airway disease appear to release a larger
number of pro-inflammatory cytokines upon exposure to allergen,
Fig. 6. Protein and mRNA expression levels of STAT3, p-STAT3, ROR-γt and SOCS3 in nasal mucosa of mice which were examined by Western Blot and PCR analysis
(n = 3 per group). Data are presented as mean ± standard deviation (SD). *P < 0.05, ***P < 0.001 vs. Control group; #P < 0.05, ##P < 0.01, ###P < 0.001 vs.
OVA group.
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thereby contributing to allergic response (Al Suleimani & Walker,
2007). This is consistent to our present result at which the IL-1β level in
OVA group was significantly higher than those in the Control group and
drug treatment groups, causing allergic inflammation in AR mice.
However, allergic response was suppressed through administration of
loratadine and LJP by lowering the level of IL-1β in mouse serum.
Th17 cell differentiation is induced by IL-6 through STAT3 pathway,
leading to ROR-γt activation. In the absence of STAT3, a key player in
IL-23 signaling pathway, abrogation of Th17 cells production occurs,
STAT3/ ROR-γt pathway is a key part of TH17 differentiation
(Commins, Borish, & Steinke, 2010; Di Cesare, Di Meglio, & Nestle,
2009; Toussirot, 2012; Wei, Laurence, & O'Shea, 2008). STAT3 that is
phosphorylated and activated by stimulation of IL-23, mediates signals
that cause Th17 cell differentiation, thus maintaining the Th17/Treg
cell balance (Commins et al., 2010; Wei et al., 2008). Our results
showed that the increased p-STAT3 and ROR-γt expression levels in
OVA group were lowered after drug application, thereby attenuated the
AR symptoms.
Suppressor of cytokine signaling protein 3 (SOCS3), an important
regulator of Th17 generation regardless of the presence of IL-6 and IL-
23. The absence of SOCS3 enhances the phosphorylation of STAT3
which is induced by IL-23 (Chen et al., 2006). Th17 cells are produced
in high concentration due to the deficiency of SOCS3 in T cells. How-
ever, the suppression of Th17 cell development occurs due to over-
expression of SOCS3 in T cells, resulting in the reduction of STAT3
phosphorylation (Qin et al., 2009). This discovery is consistent with our
experimental results, at which the concentration of SOCS3 in the OVA
group was lower than the drug treated groups, while the concentration
of STAT3 in the OVA group was higher than the drug treated groups.
In conclusion, our study also shows that LJP could trigger a broad
response of the immune system in AR, the th17 pathway which defines
a new arm of the immune response was investigated in the present
study (Fig. 7). LJP had the absorption characteristic of typical poly-
saccharides and consists of six types of monosaccharides. Apart from
that, LJP significantly inhibited several features of the allergic in-
flammatory responses which include nasal symptoms, airway eosino-
philia, IgE production and cytokines expression. Thus, LJP could be
used as an attractive immunomodulating agent in the treatment of AR
disease. The present results provide a basis data for further functional
foods application of LJP.
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